Publication | Closed Access

Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome

ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseBlood PlateletAtherosclerosisMedicineHematologyGlycoprotein Iib/iiia InhibitorAcute Coronary SyndromePharmacotherapyCoagulopathyPlatelet AntagonistPharmacologyAnticoagulantCardiologyHeparinsAcute Myocardial Infarction